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Abstract Polyoxometalates (POMs) were used, together with chitosan (CS), to
obtain hybrid nanoaggregates. Three representative POMs were efficiently assem-
bled into nanoparticles of few hundred nm diameter, featuring entangled ribbons
substructure. In order to establish suitable preparation and stability conditions, the
assemblies were characterized in solution by UV–Vis spectroscopy, dynamic light
scattering and f-potential. The nanoparticles were tested against E. coli (106 CFU/
ml) in aqueous solution, showing a synergic activity of the heteropolyacid
H5PMo10V2O40 and CS. For such components, a highly porous and antibacterial
film was obtained upon lyophilisation of the colloidal mixture.
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Introduction
Polyoxometalates (POMs) are polyanionic oxides of early series transition metals
which are characterized by an unmatched versatility in terms of structural features,
resulting in a broad range of potential applications in catalysis, material science and
medicine [1–3]. Thanks to their redox behavior, in particular, POMs have been
extensively employed as catalysts for the oxidation of organic substrates and for the
oxidative degradation of pollutants. Their bio-medical applications (antiviral,
antitumoral, antibacterial) stem from the possibility to oxidize cellular components
[4] and from their affinity towards biological molecules, which can be associated
through electrostatic interactions [5].
The development of efficient antimicrobial systems containing POMs, suitable
for water treatment, wound dressing and medical applications is an actual multi-
disciplinary challenge. Several different classes of POMs have been reported as
efficient antimicrobial agents in a number of different formulations: polyoxotung-
states were used to inhibit the growth of methicillin-resistant Staphylococcus
aureus, since they depress the formation of a penicillin-binding protein with low
affinity for b-lactams [6–9]. Then organoantimony(III)-containing heteropolytung-
states were used against Escherichia coli and Bacillus subtilis, showing a slightly
stronger activity against the latter gram-positive bacterium [10]. Polyoxovanadates
were shown to affect membrane transport of potassium and organic substrates in
Streptococcus pneumoniae [11], whereas nanocomposites containing polyoxomo-
lybdates were successfully used against gram-negative and gram-positive bacteria
[12–14].
Since POMs can interact with macromolecules, they can be loaded into
biopolymers [15–17], including chitosan (CS) and its derivatives. CS is a linear
polysaccharide constituted of b-(1,4)-D-glucosamine units, obtained from deacet-
ylation of a naturally abundant biopolymer, chitin, which is the main constituent of
the exoskeleton of crustaceans and cell wall of various fungi. Due to its availability,
ease of preparation, excellent metal coordination [18] and particles stabilization
capabilities [19, 20], CS has found application in various research field such as
biomedical sciences [21–23], food preservation [24, 25] and water treatment [26–
31]. CS has been reported to suit water disinfection applications when incorporated
into membranes, sponges, or surface coatings of water storage systems [31].
Because of its activity against bacteria, viruses and fungi, and its low toxicity
towards animals and humans, CS is widely employed as a cheap and abundant
antimicrobial agent [32, 33].
A key feature of CS is its polycationic nature at pH below its isoelectric point
(pKa = 6.28), due to the protonation of the amino groups at the C-2 positions. This
makes the biopolymer capable of promoting efficient electrostatic interaction with
macromolecules (peptides and proteins, nucleic acids), viral capsids and negatively
charged constituents on microorganism membranes [34]. Thanks to its preferential
binding to lipopolysaccharidic domains of gram-negative bacteria surface, CS can
compete with the binding sites of divalent cations, such as Mg2? or Ca2?, leading to
the disruption of outer membrane integrity, with permeabilization and leakage of
intracellular components [35]. When POMs are mixed with CS in solution, the
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positively charged groups of CS associate with the polyanions surface [36]. In
addition, terminal/bridging oxygen on POM surface may accept hydrogen bonds
from –OH and –NH3
? groups [37, 38]. Such multiple intermolecular interactions
result in the ionotropic gelation of the CS.
CS is therefore a promising candidate for the preparation of nanocomposites
embedding negatively charged POMs. Among the examples, CS and its derivatives
were used to encapsulate Eu [39, 40], Ti [41] or Co [42] substituted polyoxotung-
states, so to enhance their cell-penetration, in order to develop nanomedicinal
agents. In other cases, charged multilayered films of CS, and POMs were used as
oxidation catalysts [43, 44], H2O2 sensors [45], electrocatalysts [46, 47] and for the
preparation of luminescent films [47]. CS and decavanadate were employed in the
fabrication of a composite material, which was integrated into wound dressings,
showing antimicrobial activity against S. aureus [48] and E. coli [49]. Moreover,
the redox active Keggin dodecamolybdate [PMo12O40]
3- was incorporated into CS
and used to inhibit E. coli [50].
This work reports the synthesis and characterization of novel nanocomposites
derived from commercially available low molecular weight CS and different POMs,
namely (NH4)6V10O28 (V10) [51], H5PMo10V2O40 (Mo10V2) [52], Na4W10O32
(W10) [53] (i.e. representative vanadate, molybdate, tungstate precursors with
recognized biological effects, antibacterial activity and/or oxidative capability)
(Fig. 1).
The synthesis of CS/POM assemblies was optimized in order to obtain stable and
discrete nanoparticles, with defined size distribution. In addition, tripolyphosphate
(TPP) was added to promote the formation of CS nanoparticles through an analogue
procedure [54, 55]. In order to produce an antimicrobial material for water
disinfection, the resulting nanoparticles were preliminarily tested in solutions
containing E. coli, showing, in one cases, a synergistic activity of the two domains.
To expand the range of applicability of these hybrid nanocomposites, the active
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Fig. 1 Structures of chitosan and of the POMs used in this study
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components were then assembled in the form of an antibacterial and porous film.
Perspectives for the preparation of a coating layer for water treatment purposes are
finally herein discussed.
Experiments
Materials
Low molecular weight CS (40–90 kDa), TPP, hydroquinone (HQ) and b-nicotinamide
adenine dinucleotide (NADH) were purchased from commercial sources and used as
received. POMs (NH4)6V10O28 [56], H5PMo10V2O40 [57] and Na4W10O32 [58] were
synthesized according to reported literature procedures. Starting materials for POMs
synthesis, NH4VO3 for (NH4)6V10O28, Na2MoO42H2O and Na2HPO412H2O for
H5PV2Mo10O40, Na2WO42H2O for Na4W10O32, sodium hydroxide and glacial acetic
acid were all available from commercial sources and used without further purification.
All acidic and basic aqueous solution were prepared starting from reagent grade acids
or alkali salts. Mueller–Hinton broth (OXOID), agar–agar (Sigma–Aldrich) and
bacteriological peptone (OXOID) were used to carry out the antibacterial activity
tests. E. coli (ATCC 25922) was chosen as the test microorganism. Deionized water
was produced by a Sartorius Arium water purification system.
Characterizations
Fourier transform infrared (FT-IR) spectra were recorded with a Thermo Quest
Nicolet 5700 spectrometer, preparing KBr pellets. Analytical samples were
prepared by ultrafiltration of the nanoparticles solution with Millipore Amicon
Centrifugal Units (MWCO = 50 KDa), centrifuging for 20 min at 3,800 rpm. UV–
Vis spectra were recorded with cary 100 double beam UV–Vis spectrometers.
Measurements were performed by using quartz cuvettes (1 cm optical path). Particle
size and f-potential were obtained by dynamic light scattering (DLS) measurements,
with a Malvern Zetasizer Nano ZS90 instrument, in a quartz cuvette (1 cm optical
path) containing 1 ml of the solution under investigation. For f-potential
measurements, polymethyl methacrylate cuvettes, purchased at Malvern, were used
(V = 1 ml).
51V-NMR was performed on a Bruker AV 300, operating at 78.8 MHz, using
freshly prepared [V(O)(O2)(pic)(H2O)2] (pic = picolinate) in D2O/H2O at pH 1
(HClO4) as reference (-600 ppm).
TEM images were obtained by drop casting the nanoparticles solution on copper
grids (300 mesh). After removal of the excess water with paper, the grids were
incubated with uranyl acetate (2 % in water). The samples were observed with a
Tecnai G2 12 Twin Transmission Electron Microscopy (FEI Company).
Optical microscopy (OM) images were obtained on clean glass cover slips at
room temperature by using an Olympus CX31 optical microscope fitted with
Olympus DP25 digital camera. Micrographs were attained on E. coli samples
incubated overnight at 37 C in CS/Mo10V2 nanoparticles-combined broth, or in
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broth only, which were pipetted onto few drops of 0.1 % (w) peptone water on clean
glass cover slips for obtaining clear images.
Environmental scanning electron microscopy (ESEM) analyses were performed
on a FEI Quanta 200 microscope equipped with EDAX and BSE detectors.
Nanoparticles Preparation and Stability
CS/POM NPs suspensions were prepared as follows: the amount of CS, required to
obtain 1 mg/ml solution, was suspended in acetic acid 0.05 % v/v. The mixture was
kept under vigorous stirring for 2 h, until complete dissolution of CS. The solution was
then filtered over polycarbonate hydrophilic isopore membrane (2 lm cut-off), then pH
was measured and adjusted to the desired value by dropwise addition of 1 M NaOH. At
the same time, aqueous POM solutions (1 mg/ml) were prepared. All solutions were
sonicated for 30 min. NPs were produced by dropwise addition of the required amount
of POM solution to a known volume of CS solution, under stirring. Similarly, CS/POM/
TPP NPs were prepared by dropwise addition of the required amount of POM/TPP
solution to a known volume of CS solution under stirring (concentration and weight
ratios of the prepared nanocomposites are listed in Table S1).
The assembly efficiency was monitored by performing UV–Vis analysis of CS/
POM solutions before and after ultrafiltration (over Millipore Amicon Ultra-15
centrifugal filter units, 50 kDa MWCO, 4,000 rpm, 200). Quantification was
performed by using calibration curves of each POM. For all three POMs, the
absorption spectra of the filtered solution shows a similar pattern, suggesting that
the residual absorption was only due to the parts of CS that crossed the membrane.
POMs stability was evaluated by UV–Vis, upon comparison of their spectral
features before and after permanence in aqueous solution for 7 days.
Catalytic Tests
The aerobic oxidation of NADH was monitored by measuring the variation of UV–
Vis maximum absorbance of the reagent, at k = 339 nm. For this purpose, 2 ml of
aqueous substrate solution (50 lL) were poured in a quartz cuvette, then dioxygen
was bubbled for 2 min before POM or CS/POM addition (10 % mol of POM).
Similarly, the aerobic oxidation of HQ was monitored by measuring the variation of
UV–Vis absorbance of the reagent, at k = 245 nm. 2 ml of aqueous substrate
solution (0.18 mM) were poured inside a quartz cuvette, then dioxygen was bubbled
for 2 min before POM or CS/POM addition (10 % mol of POM). All reactions were
thermostated at 45 C.
Films Preparation
CS-based films were prepared by lyophilization of 55 ml of NPs solution, obtained
from 5 ml of 1 mg/ml aqueous solution of POM, added to 50 ml of 1 mg/ml CS in
water (with 0.05 % acetic acid).
For the preparation of the glycerol-stabilized film, a 1 % (w/v) CS solution in
1 % acetic acid was prepared under stirring for 15 min. Glycerol (30 % w/w with
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respect to CS) was then added. Stirring went on for 30 min, so to obtain the total
homogenization of the mixture. Finally, the volume of PMo10V2 (1 mg/ml aqueous
solution), required to obtain a final 10:1 (CS/POM, w/w) ratio, was quickly added to
the CS/glycerol solution. The resulting mixture was poured in a petri dish, and
evaporated to dryness at room temperature for 3 days.
Antibacterial Tests
Antibacterial tests were performed on E. coli bacteria strains. Muller-Hinton (MH)
broth and MH agar were used as growth media. E. coli was inoculated onto agar and
incubated for 18 h at 37 C for the activation of bacteria. After incubation, the
initial E. coli concentration was adjusted by picking off bacteria colonies with a
swap from the MH agar plate and mixing them with 0.1 % w/w peptone water, till
they reached a Mc Farland value of 0.5, which corresponds to approximately 108
Colony Forming Units per ml (CFU/ml).
All the materials were sterilized at standard conditions, i.e. 120 C, 15 psi and for
300 before use. Different concentrations of CS NPs, 0.6, 0.5 and 0.3 mg/ml, were
tested against E. coli. For this purpose, 100 ll of the E. coli solution were added
into 10 ml of CS nanoaggregates containing MH broth to reach an initial bacteria
concentration of *106 CFU/ml in sterilized tubes, and were further incubated at
37 C for 24 h. Control samples of MH broth (10 ml) containing only E. coli
(100 ll) were prepared. Five replicates of each sample were prepared for the tests,
so to provide statistical confidence. After incubation, the sample solutions were
serially diluted over anticipated orders of magnitude and 100 ll samples were
plated onto triplicate MH agar plates using pour-plate method. The plated petri
dishes were further incubated at 37 C for 24 h. After incubation, colonies formed
on plates were counted and the microbial counts in the original tubes prior to
dilution were calculated as CFU/ml. The antibacterial activity of CS NPs was
measured as the reduction in number of colonies for CS NPs-treated samples in
comparison to the untreated control sample.
For evaluating the antibacterial properties of film samples, an E. coli solution in
MH broth was serially diluted with MH broth to 100 CFU/ml from a stock of 106 CFU/
ml. Subsequently, 0.6 ml of the diluted solution, which corresponds to 60 CFU, were
spread onto the films. Prior to overnight incubation at 37 C on MH agar plates, films
were subjected to 3 h of preincubation (which involves waiting for complete
absorption of bacteria solution on film surface at room temperature before imprinting
them on MH agar plates). After 24 h incubation period had elapsed, the number of
bacteria present on the film surface was compared to the initial 60 CFU/ml seeded.
Results and Discussion
Nanoparticles Characterization
CS/POM and CS/POM/TPP nanoparticles were prepared by exploiting electrostatic
interactions of the oppositely charged building blocks, i.e. by mixing aqueous
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solutions containing the polycation (CS) and the appropriate polyanion, optimizing
the procedure for three different POMs. In order to obtain nanoaggregates featuring
homogeneous size distribution, different preparation routes were explored. DLS
analysis and f-potential measurements were conducted to monitor the influence of
pH and of the ratio between polycation and polyanion concentrations, on the
observed hydrodynamic diameter and polydispersity index (PDI). The effect of pH
on NPs size was initially verified by preparing CS/POM assemblies at a fixed CS/
POM ratio (10:1 w/w) and at different pH values (3.7, 4.9 and 6.0), so to establish
suitable conditions for obtaining smaller particles with low size dispersion. Average
NP diameters were found between 100 and 420 nm (Table S2). For the three
different CS/POM combinations, the average particle size measured was generally
higher at lower pH, ranging from 160 nm for Mo10V2 to 420 nm for V10
(pH = 3.7), whereas, at higher pH, the size range was narrower (105–175 nm at
pH = 6.0, Table S2 and Fig. S1). This behavior is in agreement with DLS analysis
of acidic CS solutions: the overall positive charge of CS strands increases at lower
pH, making the macromolecules more rigid, due to intramolecular repulsions, thus
increasing their hydrodynamic radius [59]. In addition, although the measured PDI
values did not display a linear behavior as a function of the pH, they were found to
be lower at pH *6 for all CS/POM (0.36–0.46, Table S2).
NPs with different CS/POM (from 50:1 to 5:1) weight ratio were thus prepared
at pH = 6.0 and characterized by DLS to evaluate the effect of POM loading on the
resulting NPs. For Mo10V2 and W10, larger particles (430–490 nm) were obtained
at low POM content (CS/POM 50:1 w/w). An opposite trend was observed with
V10, for which a narrower size range (188–235 nm) was observed. A ratio CS/POM
10:1 w/w was hence adopted to provide smaller particles with high loading
(Table 1).
In order to evaluate assembly features and colloidal stability of the NPs with
different formulation, f-potential measurements were performed in aqueous
solution, including the analysis of the isolated CS and POM at different pH.
For CS, the observed f-potential was in agreement with literature data, yielding a
Table 1 Effect of CS:POM ratio on size and PDI of NPs prepared at pH 6
# CS:POM
(w/w)
POM Diameter
(nm)
PDI f-potential
(mV)
1 50:1 Mo10V2 430 0.56 32
2 10:1 Mo10V2 220 0.48 24
3 5:1 Mo10V2 254 0.49 32
4 50:1 W10 490 0.48 32
5 10:1 W10 175 0.42 22
6 5:1 W10 246 0.42 26
7 50:1 V10 188 0.52 26
8 10:1 V10 220 0.38 18
9 5:1 V10 235 0.32 5
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positive potential of 26 mV [60]. Negative f-potential values were observed for
the three POMs, in all the pH range explored, with values between -9 and
-40 mV (Fig. S2). Such broad range may be due to counterion-mediated
attraction between the polyanions, which results in a partial charge shielding [61].
In addition, the wider f-potential range observed for V10 is likely to result from
equilibria involving the formation of lower nuclearity oxovanadates (V1–V5) at
higher pH [62].
f-potential measurements obtained from freshly prepared CS/POMs solutions
gave positive values in all cases (Fig. S3 and Table 1). For CS/Mo10V2 and CS/
W10, in particular, the observed values are similar or even higher than that of the CS
at pH = 6, suggesting that the POMs are fully encapsulated into the NPs, with small
effects on the surface charge density of the particles. In such conditions, the
repulsion potential between the aggregates seems to be large enough to prevent their
fast coalescence and flocculation, without needing any undesired surfactant [63]. In
the case of V10, the decrease in the observed f-potential absolute value is consistent
with NPs bearing surface exposed oxovanadates.1 Ammonium ions may contribute
to such behaviour, establishing additional weak interactions between the polyanions
and CS. The low f-potential of these particles is likely responsible for the opposite
dimension trend (Table 1).
POM Encapsulation Efficiency and NPs Stability
The encapsulation efficiency of the resulting CS/POM nanocomposites was
evaluated by UV–Vis analysis of the CS/POM solution before and after
ultrafiltration. Data were calculated by the UV–Vis measurement in the interval
245–277 nm, where the POMs show absorbance peaks (Fig. S4–S6). The
encapsulation percentage was high (88–99 %, see Table S3), especially for W10
(Fig. S6), suggesting an efficient interaction between the POMs and CS charged
domains. The same procedure was applied to evaluate the encapsulation efficiency
into CS in the presence of TPP. For all three POMs, NPs were prepared adding a
solution of POM and TPP in ratio of 5:2 (w/w) to a solution of CS 0.05 % (w/v).
The encapsulation efficiency turned out to be higher than 82 % in all cases, as
shown by the UV–Vis spectra (Fig. S7–S9 and Table S3). However, a decreased
encapsulation efficiency was observed for all the TPP based NPs, particularly for
V10 and W10 containing NPs. This behaviour is ascribable to the competition
between the polyanionic species (POM and TPP) in the NPs formation process.
Modification of the NPs components was evaluated by UV–Vis measurements on
aqueous solutions containing the solute of interest, over several days. In none of the
cases a significant change in the absorption spectra was observed (Fig. S10–S12).
CS/Mo10V2 NPs stability was further studied by UV–Vis spectroscopy and DLS.
After 24 h, we observed a 30 % increase in diameter and a lowering of f-potential
1 In the presence of a small amount of CS, Mo10V2 and V10 gave very broad
51V-NMR signals centred,
respectively, at -500 and -550 ppm. The latter value is in agreement with the occurrence of V1–V5 oxo-
species [62].
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(from -24 to -31 mV). POM release in water was however excluded by checking
of ultrafiltered surnatant solutions, since POM absorbance was not detected.
Electronic Microscopy
CS/POM NPs morphology was characterized by transmission electron microscopy
(TEM). The images (Fig. 2) show nanoaggregates in the range of hundred nm,
without any evidence of phase separation. In all cases, NPs with irregular shapes
were observed, while the different dimensions observed in solution (DLS) and at the
solid state are likely due to the instability of the assemblies under vacuum condition
required for TEM analyses. Bundles with ribbon-like substructure, which are
particularly defined for CS/V10, can be observed. This behaviour is different from
that observed with other procedures, that led to spherical POM/CS nanoparticles
[38, 40].
For all compositions, TPP has a minor effect in improving the aggregation (Fig.
S13–S15), while, in the absence of POMs, CS/TPP nanoparticles were irregularly
shaped, lacking in defined substructural features (Fig. S16).
Antimicrobial Activity
The antibacterial activities of the CS NPs prepared at pH 6 by using TPP (CS/
TPP = 50:2 w/w), POM (CS/POM = 10:1 w/w) or a combination of both (CS/TPP/
POM = 50:5:2 w/w) were tested against E. coli (ATCC 25922). In addition, CS (at
pH = 6) and Mo10V2 were tested separately to prove their individual antibacterial
activity. Results were compared to a control case assay of untreated E. coli bacteria.
CS NPs were added to provide a POM concentration between 0.6 and 0.3 mg/ml.
Mo10V2 solution was employed at 0.6 mg/ml dose only, while CS was added in a
concentration corresponding to that required to achieve the 0.6 mg/ml dose. The
results of antibacterial activity tests are summarized in Fig. 3 and in Table S4. A
dose-dependent effect on bacteria inhibition was observed for all the NPs solutions
tested. The best results were obtained at 0.6 mg/ml, the highest applied dose: CS/
Mo10V2 and CS/TPP/Mo10V2 nanoparticles completely inhibited bacterial growth,
CS/TPP resulted in eightfold decrease in bacteria count, while CS/W10 and CS/V10
Fig. 2 TEM images of NPs of CS/Mo10V2, CS/V10, CS/W10 (CS/POM = 10:1)
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NPs led to sevenfold decrease. The antibacterial effect of CS/Mo10V2 nanoparticles
at 0.6 mg/ml highlights the synergistic antimicrobial activity of CS and Mo10V2,
since the separate components did not display the same effect, causing only seven
and sixfold declines in bacteria count, respectively (Fig. 3). At 0.5 mg/ml dose, all
the NPs studied displayed a lower antibacterial activity. Antibacterial activities of
CS/Mo10V2, CS/W10 and CS/TPP/Mo10V2 nanoparticles were almost the same at
this dose, resulting in sevenfold reduction on average, and higher compared to CS/
TPP and CS/V10 agents, both of which cause threefold reduction in bacteria count.
At a 0.3 mg/ml dosage, bacterial growth was scarcely inhibited by adding NPs, even
if the highest antibacterial activity was still observed with CS/Mo10V2 nanopar-
ticles, which caused a twofold reduction.
The optical microscope observations of E. coli incubated overnight at 37 C with
CS/Mo10V2 nanoparticles are reported in Fig. S17. The extensive degradation of the
microorganisms is witnessed by the disruption of their rod-shaped morphology,
resulting in their precipitation in the form of distinctive clusters.
Variations in parameters such as the average molecular weight of CS, the type of
cross-linking agent, the average nanoparticle size (nm) and the nanoparticle surface
charge (mV) strongly affect the antibacterial activities of CS NPs [64–67].
Concerning CS/POM composites, Chen et al. [49] found that V10/Ca
2?/CS
membranes display improved antibacterial activity with respect to the isolated
components CS and V10O68
6-. However, the different state of POM (amorphous
crystals of Ca2? salt of V10, featuring size smaller than 50 nm) led to specific
Fig. 3 Bacteria count at different concentration of antimicrobial agents. Antibacterial activity is
expressed as the decrease in number of E. coli colony-forming units (CFU/ml) compared to the control
case, following overnight incubation
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distinct properties of the resulting assembly, pointing out the significance of the
conditions adopted in the synthesis.
Among several mechanisms proposed for antimicrobial activities of metal/metal
oxides, impairment of membrane architecture through electrostatic repulsion [13]
and oxidative degradation have been commonly acknowledged [68]. As a matter of
fact, POMs have already been used to promote electron transfer (ET) reactions with
biologically relevant substrates, highlighting their major role as electron acceptors
[6]. The oxidative power of the POMs under investigation is thus expected to be a
key factor for better performances. The ET activity of the title POMs was evaluated
in aqueous environment, with or without CS, by performing the aerobic oxidation of
reduced b-nicotinamide adenine dinucleotide (NADH) and HQ. NADH and its
oxidized form (NAD?) are coenzymes that play an essential role in metabolism as
electron carriers [69]. As a result NADH (E0 = -0.32 V vs NHE) is smoothly
oxidized by all POMs, with conversion of 70–83 % in 10 h (Fig. 4) [70–73].
Moreover, Mo10V2 into CS is still able to oxidize NADH (83 % conversion in
10 h).
HQ has been chosen as a model substrate of reduced ubiquinone, a molecule
involved in the respiratory chain. At pH = 6, HQ can be oxidized (E0 = 0.7 V vs
NHE) by the POMs to its corresponding dicarbonyl product, p-benzoquinone (BQ)
[74, 75], whereby dioxygen is responsible for catalyst re-oxidation [76]. Because of
its higher reduction potential, only Mo10V2 (E
0 = 0.7 V vs NHE) converts HQ into
BQ (27 % yield in 15 h), upon reduction of V(V) ions to V(IV) [77, 78]. In this
case, the reaction by CS/Mo10V2 was slower (6 % yield in 15 h, Fig. S18–S19).
Considering this scenario, the enhanced efficiency of CS/POM likely benefits
from the attractive forces between positively charged CS and negatively charged
membrane components [36]: beside causing outer membrane permeabilization, CS
guarantees the contact between the POM and the membrane. The lower antibacterial
activity displayed by CS/V10 nanoparticles can thus be explained by their decreased
f-potential, in comparison to the other nanoparticles, including CS/TPP. This
finding is in agreement with the work of Du et al. [79], who studied CS
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Fig. 4 Oxidation scheme of NADH (50 lL in water) and UV–Vis spectra collected during the reaction
in the presence of 10 % mol Mo10V2, at 45 C; kinetic traces were obtained monitoring the absorbance at
339 nm. In the absence of POMs, 43 % NADH was oxidized in 10 h
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nanoparticles loaded with different metal ions and concluded that the antibacterial
activity is directly correlated with the f-potential of resulting nanoparticles. Then it
was demonstrated that size and shape of nanoparticles may lead to differences in
contact area, significantly altering the antimicrobial activity. In fact, smaller metal
nanoparticles showed enhanced antimicrobial properties toward E. coli than larger
particles, due to their larger contact surface area (compared to the volume) [65, 80].
In addition, the flexible shape of CS nanoaggregates, with respect to other
nanoparticles, may guarantee a better contact with bacterial membrane. TEM
images (Fig. 2), stress out the relatively small size and irregular shape of CS/
Mo10V2 nanoparticles, matching these requirements.
Preparation of an Antimicrobial Film
CS/Mo10V2 NPs shows antibacterial activity at high doses. Nevertheless, such
hybrid assembly is expected to benefit from material design [14, 81–83],
immobilization on solid substrates [84] and cross-linking [85, 86]. The specimens
were thus lyophilized to obtain composite films, which were analyzed at the solid
state by ESEM. The microscopy shows a network of fibers (Fig. 5, S21, S24), likely
resulting from the growth of the nano-ribbons shaped structures. While the POM-
free CS is richer in film-like regions (Fig. S20), the cross-linking effect of the POMs
is more evident for CS/Mo10V2, which is characterized by a homogeneous network
of fibers (with length upto hundreds of lm), with a diameter between 2 and 12 lm,
in agreement with an efficient cross-linking effect of the polyanion. EDAX (Energy
dispersive X-ray spectroscopy) microanalysis confirmed the material composition
(Fig. S22, S25 and S28), with no phase separation. The strong contrast observed by
TEM is in agreement with an even POM distribution throughout the fibers (Fig.
S27).
In addition, polyanions bands can be detected by FT-IR spectroscopy in the
region between 600 and 1,050 cm-1 (Fig. S23, S26, S29). At variance with
previously reported CS/POM films, these exhibit high porosity, flexibility and
complete embedding of the POM [41, 45, 49, 87, 88]. Since the hybrid materials is
insoluble and does not show POM leaching, it is promising for the development of
porous antimicrobial coatings for water treatments.
In order to evaluate the antibacterial properties of the solid CS/Mo10V2 sample,
an E. coli solution including 60 CFU/ml was spread onto the films. After overnight
incubation at 37 C, bacteria growth was completely inhibited on film surface, while
the CS sample surface was covered with bacteria, manifesting that a strong
antibacterial activity is imparted to the film only when CS is loaded with Mo10V2.
Finally, a preliminary test for the development of mechanically resistant films of
CS/Mo10V2, containing glycerol as plasticizer additive, was undertaken [89].
Glycerol is indeed expected to foster further cross-linking between carbohydrate
chains through hydrogen bonding. The resulting dense and homogeneous film, with
30 lm thickness (Fig. S30), however, did not inhibit the E. coli bacteria growth
completely, strengthening the superior performances of CS/POM in the form of a
flexible and porous structure. Further experiments will be aimed at tuning
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mechanical properties and testing filtrating capabilities of the composite films, upon
addition of different cross-linking agents.
Conclusions
A series of organic–inorganic nanomaterials based on CS and different POMs were
prepared and characterized in order to establish suitable conditions for obtaining
small NPs featuring high POM loading. Our results point to investigate the
performance of the composite material against E. coli (gram negative bacterium),
demonstrating the key role of both components to enhance the activity. The best
antibacterial activity was obtained with the NPs prepared by using H5PV2Mo10O40
as crosslinking agent. The synergic activity of CS and the molybdovanadate likely
springs from CS-mediated membrane destabilization, coupled with POM-mediated
oxidation of substrates involved in the electron transport chain. Such multiple
degradation effects lead to lethal cell damages, as demonstrated by the loss of rod-
shape morphology and the decrease of viable counts.
The most efficient composite can be prepared in the form of a stable film, without
affecting the observed antimicrobial power. In this case, the synergistic activity of
the two components was even more important. Performances of the porous film will
be evaluated upon integration into a water treatment device.
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